October 1, 2024

An Expanded Role for Faricimab?

By Lauren Pickel, BS, Nirojini Sivachandran, MD, PhD, FRCSC

October 1, 2024

An Expanded Role for Faricimab?

By Lauren Pickel, BS, Nirojini Sivachandran, MD, PhD, FRCSC

July 1, 2024

FDA Approves First Biosimilars to Eylea

July 1, 2024

New Horizons in Vision Enhancement

By Kapil G. Kapoor, MD, FACS, FICS, FASRS

July 1, 2024

FDA Approves First Biosimilars to Eylea

July 1, 2024

New Horizons in Vision Enhancement

By Kapil G. Kapoor, MD, FACS, FICS, FASRS

March 26, 2024

CMS Assigns Permanent J-code J2782 for Izervay Injection

January 25, 2024

FDA Modifies Axpaxli Trial Protocol

July 1, 2022

So You Have Diagnosed MacTel—Now What?

By Zack Oakey, MD

July 1, 2021

Strategies for Treating Diabetic Macular Edema

By AHMED M. ALKALIBY, MD, MS, FICO, MRCS EDINBURGH

June 1, 2021

Innovative Surgical Techniques

By CHIRAG JHAVERI, MD

June 1, 2021

Age-Related Macular Degeneration: Challenges of the Baby Boom

By BETH RICHTER, MD, PHD